Unresectable Or Metastatic Soft Tissue Sarcoma clinical trials

Explore recruiting unresectable or metastatic soft tissue sarcoma clinical trials.

Recruiting unresectable or metastatic soft tissue sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Unresectable Or Metastatic Soft Tissue Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma

Spain, France, Germany, Poland, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory soft tissue sarcoma (STS), Acronym: TRABTRAP

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I dose escalation study of DPPG2-TSL-DOX combined with hyperthermia in soft tissue sarcoma

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A randomized study to investigate the efficacy and safety of the tumor-targeting human antibody-cytokine fusion protein L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcoma

Germany, Italy, Poland, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

CONGRATS : COMBINATION OF NIVOLUMAB PLUS RELATLIMAB IN PATIENTS WITH ADVANCED OR METASTATIC SOFT-TISSUE SARCOMA: A PROOF-OF-CONCEPT RANDOMIZED PHASE II STUDY

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

Germany, Portugal, France, Spain, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Unresectable Or Metastatic Soft Tissue Sarcoma trials by city

Unresectable Or Metastatic Soft Tissue Sarcoma clinical trials

Recruiting unresectable or metastatic soft tissue sarcoma studies right now

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

ACTengine® IMA203 Combined With mRNA-4203

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study